POSTAFEN

This brand name is authorized in Finland

Active ingredients

The drug POSTAFEN contains one active pharmaceutical ingredient (API):

1 Meclozine UNII L997QXC9J1 - MECLIZINE HYDROCHLORIDE ANHYDROUS
Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness. Read about Meclozine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AE05	Meclozine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 066568

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.